In vitro differential effects of the antiglucocorticoid RU486 on the release of lymphokines from mitogen-activated normal human lymphocytes

This publication has 23 references indexed in Scilit:

• Synergistic induction of apoptosis with glucocorticoids and 3',5'- cyclic adenosine monophosphate reveals agonist activity by RU 486
  Molecular Endocrinology, 1993
• The antiglucocoticoid RU486 downregulates the expression of interleukin-2 receptors in normal human lymphocytes
  The Journal of Steroid Biochemistry and Molecular Biology, 1991
• Cytokine Regulation of Human Endometrial Function^a
  Annals of the New York Academy of Sciences, 1991
• Treatment of breast cancer with different antiprogestins: Preclinical and clinical studies
  The Journal of Steroid Biochemistry and Molecular Biology, 1990
• Contragestion and Other Clinical Applications of RU 486, an Antiprogesterone at the Receptor
  Science, 1989
• Interferon-Gamma, the Activated Macrophage, and Host Defense Against Microbial Challenge
  Annals of Internal Medicine, 1988
• Lymphokines
  New England Journal of Medicine, 1987
• Termination of Early Pregnancy by the Progesterone Antagonist RU 486 (Mifepristone)
  New England Journal of Medicine, 1986
• The Antiprogestin RU38 486: Receptor-Mediated ProgestinVersusAntiprogestin Actions Screened in Estrogen-Insensitive T47D_COHuman Breast Cancer Cells*
  Endocrinology, 1985
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
  Analytical Biochemistry, 1976